{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:13:32Z","timestamp":1791879212465,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008977","name":"Universit\u00e4t Ulm","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008977","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of the study was to analyze the impact of concomitant coronary artery disease (CAD) assessed by the SYNTAX score (SS) and periprocedural percutaneous coronary intervention (PCI) on outcomes after transcatheter aortic valve replacement (TAVR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Due to controversial data regarding the effect of CAD on outcomes after TAVR, proper revascularization strategies remain a matter of debate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>553 patients with severe aortic stenosis undergoing TAVR were included in this study. SS was calculated for each patient at baseline and after PCI. Primary outcome was one-year all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      60.2% of patients (N\u2009=\u2009333) exhibited CAD with a mean SS of 10.8\u2009\u00b1\u20098.8. Of those, 120 patients (36.0%) received periprocedural PCI. In the treatment group, mean SS was decreased from 14.9\u2009\u00b1\u20099.1 to 6.3\u2009\u00b1\u20096.7. Patients with concomitant CAD suffered more frequently from myocardial infarction (MI) post TAVR compared to those without CAD (2.1% vs. 0.0%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). In the CAD cohort, MI rates were comparable between patients with and without PCI (2.2% vs. 2.5%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.71). Regarding SS, patients with a residual SS\u2009&lt;\u20098 showed significant lower rates of one-year mortality (9.0% vs. 18.2%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.016) and MACCE (16.5% vs. 32.2%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001). Besides left bundle brunch, predictors for an increased one-year mortality were a residual SS\u2009\u2265\u20098 in the CAD group (OR\u2009=\u20093.17;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.011) and a EuroSCORE\u2009\u2265\u20094% in the entire study population (OR\u2009=\u20092.18;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.017).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results suggest that a residual SS-guided revascularization strategy may improve prognosis after TAVR in patients with concomitant CAD. PCI aiming for a residual SS\u2009&lt;\u20098 was associated with improved one-year clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-021-02374-y","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T14:25:23Z","timestamp":1638282323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of extent of coronary artery disease and percutaneous revascularization assessed by the SYNTAX score on outcomes following transcatheter aortic valve replacement"],"prefix":"10.1186","volume":"21","author":[{"given":"Tilman","family":"Stephan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Thoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rattka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Felbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Buckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Rottbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgid","family":"Gonska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinisa","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"2374_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0002-9149(88)91375-6","volume":"62","author":"A Vandeplas","year":"1988","unstructured":"Vandeplas A, Willems JL, Piessens J, De Geest H. Frequency of angina pectoris and coronary artery disease in severe isolated valvular aortic stenosis. Am J Cardiol. 1988;62:117\u201320.","journal-title":"Am J Cardiol"},{"issue":"1216\u20137","key":"2374_CR2","first-page":"A7","volume":"87","author":"AH Rapp","year":"2001","unstructured":"Rapp AH, Hillis LD, Lange RA, Cigarroa JE. Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris. Am J Cardiol. 2001;87(1216\u20137):A7.","journal-title":"Am J Cardiol"},{"issue":"185","key":"2374_CR3","first-page":"e7","volume":"120","author":"R Alcalai","year":"2007","unstructured":"Alcalai R, Viola N, Mosseri M, Beeri R, Leibowitz D, Lotan C, Gilon D. The value of percutaneous coronary intervention in aortic valve stenosis with coronary artery disease. Am J Med. 2007;120(185):e7-13.","journal-title":"Am J Med"},{"key":"2374_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","volume":"29","author":"BF Stewart","year":"1997","unstructured":"Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630\u20134.","journal-title":"J Am Coll Cardiol"},{"key":"2374_CR5","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(09)60211-7","volume":"373","author":"BA Carabello","year":"2009","unstructured":"Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009;373:956\u201366.","journal-title":"Lancet"},{"key":"2374_CR6","doi-asserted-by":"crossref","unstructured":"American College of Cardiology\/American Heart Association Task Force on Practice G, Society of Cardiovascular A, Society for Cardiovascular A, Interventions, Society of Thoracic S, Bonow RO, Carabello BA, Kanu C, de Leon AC, Jr., Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL and Riegel B. ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:e84-231.","DOI":"10.1161\/CIRCULATIONAHA.106.176857"},{"key":"2374_CR7","doi-asserted-by":"crossref","unstructured":"Likosky DS, Sorensen MJ, Dacey LJ, Baribeau YR, Leavitt BJ, DiScipio AW, Hernandez F, Jr., Cochran RP, Quinn R, Helm RE, Charlesworth DC, Clough RA, Malenka DJ, Sisto DA, Sardella G, Olmstead EM, Ross CS, O'Connor GT and Northern New England Cardiovascular Disease Study G. Long-term survival of the very elderly undergoing aortic valve surgery. Circulation. 2009;120:S127\u201333.","DOI":"10.1161\/CIRCULATIONAHA.108.842641"},{"key":"2374_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ejcts.2007.06.012","volume":"32","author":"YS Tjang","year":"2007","unstructured":"Tjang YS, van Hees Y, Korfer R, Grobbee DE, van der Heijden GJ. Predictors of mortality after aortic valve replacement. Eur J Cardio-thorac Surg. 2007;32:469\u201374.","journal-title":"Eur J Cardio-thorac Surg"},{"key":"2374_CR9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jacc.2012.10.049","volume":"61","author":"JM Beach","year":"2013","unstructured":"Beach JM, Mihaljevic T, Svensson LG, Rajeswaran J, Marwick T, Griffin B, Johnston DR, Sabik JF 3rd, Blackstone EH. Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2013;61:837\u201348.","journal-title":"J Am Coll Cardiol"},{"key":"2374_CR10","doi-asserted-by":"crossref","unstructured":"Lytle BW, Cosgrove DM, Goormastic M and Loop FD. Aortic valve replacement and coronary bypass grafting for patients with aortic stenosis and coronary artery disease: early and late results. Eur Heart J. 1988;9 Suppl E:143\u20137.","DOI":"10.1093\/eurheartj\/9.suppl_E.143"},{"key":"2374_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0022-5223(19)35524-2","volume":"100","author":"O Lund","year":"1990","unstructured":"Lund O, Nielsen TT, Pilegaard HK, Magnussen K, Knudsen MA. The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg. 1990;100:327\u201337.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2374_CR12","doi-asserted-by":"crossref","unstructured":"Sankaramangalam K, Banerjee K, Kandregula K, Mohananey D, Parashar A, Jones BM, Jobanputra Y, Mick S, Krishnaswamy A, Svensson LG and Kapadia SR. Impact of Coronary Artery Disease on 30-Day and 1-Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis. Journal of the American Heart Association. 2017;6.","DOI":"10.1161\/JAHA.117.006092"},{"key":"2374_CR13","doi-asserted-by":"crossref","unstructured":"Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Munoz D, Rosenhek R, Sjogren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL and Group ESCSD. 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739-2791","DOI":"10.1016\/j.rec.2017.12.013"},{"key":"2374_CR14","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.cjca.2017.03.016","volume":"33","author":"MT Finn","year":"2017","unstructured":"Finn MT, Nazif TM, Fried J, Labbe BM, Mohammadi S, Leon MB, Kodali SK, Rodes-Cabau J, Paradis JM. Coronary Revascularization in Patients Undergoing Transcatheter Aortic Valve Replacement. Can J Cardiol. 2017;33:1099\u2013109.","journal-title":"Can J Cardiol"},{"key":"2374_CR15","doi-asserted-by":"crossref","unstructured":"Witberg G, Zusman O, Codner P, Assali A and Kornowski R. Impact of Coronary Artery Revascularization Completeness on Outcomes of Patients With Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis of Studies Using the Residual SYNTAX Score (Synergy Between PCI With Taxus and Cardiac Surgery). Circulation Cardiovascular interventions. 2018;11:e006000.","DOI":"10.1161\/CIRCINTERVENTIONS.117.006000"},{"key":"2374_CR16","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(13)60108-7","volume":"381","author":"V Farooq","year":"2013","unstructured":"Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, Kappetein AP, Colombo A, Holmes DR Jr, Mack M, Feldman T, Morice MC, Stahle E, Onuma Y, Morel MA, Garcia-Garcia HM, van Es GA, Dawkins KD, Mohr FW, Serruys PW. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013;381:639\u201350.","journal-title":"Lancet"},{"key":"2374_CR17","doi-asserted-by":"crossref","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)\/American College of Cardiology (ACC)\/American Heart Association (AHA)\/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231\u20132264.","DOI":"10.1016\/j.jacc.2018.08.1038"},{"key":"2374_CR18","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","volume":"363","author":"MB Leon","year":"2010","unstructured":"Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, Investigators PT. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597\u2013607.","journal-title":"N Engl J Med"},{"key":"2374_CR19","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","volume":"374","author":"MB Leon","year":"2016","unstructured":"Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG, Investigators P. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609\u201320.","journal-title":"N Engl J Med"},{"key":"2374_CR20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrcardio.2016.9","volume":"13","author":"E Danson","year":"2016","unstructured":"Danson E, Hansen P, Sen S, Davies J, Meredith I, Bhindi R. Assessment, treatment, and prognostic implications of CAD in patients undergoing TAVI. Nat Rev Cardiol. 2016;13:276\u201385.","journal-title":"Nat Rev Cardiol"},{"key":"2374_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/heart.84.3.347","volume":"84","author":"B Iung","year":"2000","unstructured":"Iung B. Interface between valve disease and ischaemic heart disease. Heart. 2000;84:347\u201352.","journal-title":"Heart"},{"key":"2374_CR22","doi-asserted-by":"publisher","first-page":"e1169","DOI":"10.4244\/EIJ-D-18-00098","volume":"14","author":"F D'Ascenzo","year":"2018","unstructured":"D\u2019Ascenzo F, Verardi R, Visconti M, Conrotto F, Scacciatella P, Dziewierz A, Stefanini GG, Paradis JM, Omede P, Kodali S, D\u2019Amico M, Rinaldi M, Salizzoni S. Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results. EuroIntervention. 2018;14:e1169\u201377.","journal-title":"EuroIntervention"},{"key":"2374_CR23","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00392-012-0486-5","volume":"101","author":"M Abdel-Wahab","year":"2012","unstructured":"Abdel-Wahab M, Zahn R, Horack M, Gerckens U, Schuler G, Sievert H, Naber C, Voehringer M, Schafer U, Senges J, Richardt G. Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry. Clin Res Cardiol. 2012;101:973\u201381.","journal-title":"Clin Res Cardiol"},{"key":"2374_CR24","doi-asserted-by":"crossref","unstructured":"Dewey TM, Brown DL, Herbert MA, Culica D, Smith CR, Leon MB, Svensson LG, Tuzcu M, Webb JG, Cribier A and Mack MJ. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg. 2010;89:758\u201367; discussion 767.","DOI":"10.1016\/j.athoracsur.2009.12.033"},{"key":"2374_CR25","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1016\/j.ijcard.2013.03.062","volume":"168","author":"F D'Ascenzo","year":"2013","unstructured":"D\u2019Ascenzo F, Conrotto F, Giordana F, Moretti C, D\u2019Amico M, Salizzoni S, Omede P, La Torre M, Thomas M, Khawaja Z, Hildick-Smith D, Ussia G, Barbanti M, Tamburino C, Webb J, Schnabel RB, Seiffert M, Wilde S, Treede H, Gasparetto V, Napodano M, Tarantini G, Presbitero P, Mennuni M, Rossi ML, Gasparini M, Biondi Zoccai G, Lupo M, Rinaldi M, Gaita F, Marra S. Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: a meta-analysis of adjusted observational results. Int J Cardiol. 2013;168:2528\u201332.","journal-title":"Int J Cardiol"},{"key":"2374_CR26","doi-asserted-by":"crossref","unstructured":"Ussia GP, Barbanti M, Colombo A, Tarantini G, Petronio AS, Ettori F, Ramondo A, Santoro G, Klugmann S, Bedogni F, Antoniucci D, Maisano F, Marzocchi A, Poli A, De Carlo M, Fiorina C, De Marco F, Napodano M, Violini R, Bortone AS, Tamburino C and CoreValve Italian Registry I. Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: insight from the Italian CoreValve Registry. Int J Cardiol. 2013;167:943\u201350.","DOI":"10.1016\/j.ijcard.2012.03.089"},{"key":"2374_CR27","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jcin.2011.02.018","volume":"4","author":"S Garg","year":"2011","unstructured":"Garg S, Sarno G, Girasis C, Vranckx P, de Vries T, Swart M, Bressers M, Garcia-Garcia HM, van Es GA, Raber L, Campo G, Valgimigli M, Dawkins KD, Windecker S, Serruys PW. A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc Interv. 2011;4:645\u201353.","journal-title":"JACC Cardiovasc Interv"},{"key":"2374_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jacc.2010.03.044","volume":"56","author":"JJ Wykrzykowska","year":"2010","unstructured":"Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P, Windecker S, Serruys PW. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. J Am Coll Cardiol. 2010;56:272\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"2374_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1136\/heartjnl-2013-304273","volume":"100","author":"V Farooq","year":"2014","unstructured":"Farooq V, Head SJ, Kappetein AP, Serruys PW. Widening clinical applications of the SYNTAX Score. Heart. 2014;100:276\u201387.","journal-title":"Heart"},{"key":"2374_CR30","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1093\/eurheartj\/ehu074","volume":"35","author":"GG Stefanini","year":"2014","unstructured":"Stefanini GG, Stortecky S, Cao D, Rat-Wirtzler J, O\u2019Sullivan CJ, Gloekler S, Buellesfeld L, Khattab AA, Nietlispach F, Pilgrim T, Huber C, Carrel T, Meier B, Juni P, Wenaweser P, Windecker S. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation. Eur Heart J. 2014;35:2530\u201340.","journal-title":"Eur Heart J"},{"key":"2374_CR31","doi-asserted-by":"crossref","unstructured":"Kotronias RA, Kwok CS, George S, Capodanno D, Ludman PF, Townend JN, Doshi SN, Khogali SS, Genereux P, Herrmann HC, Mamas MA and Bagur R. Transcatheter aortic valve implantation with or without percutaneous coronary artery revascularization strategy: a systematic review and meta-analysis. J Am Heart Assoc. 2017;6.","DOI":"10.1161\/JAHA.117.005960"},{"key":"2374_CR32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.4244\/EIJV7I5A89","volume":"7","author":"P Wenaweser","year":"2011","unstructured":"Wenaweser P, Pilgrim T, Guerios E, Stortecky S, Huber C, Khattab AA, Kadner A, Buellesfeld L, Gloekler S, Meier B, Carrel T, Windecker S. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention. 2011;7:541\u20138.","journal-title":"EuroIntervention"},{"key":"2374_CR33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/ccd.25233","volume":"83","author":"Y Abramowitz","year":"2014","unstructured":"Abramowitz Y, Banai S, Katz G, Steinvil A, Arbel Y, Havakuk O, Halkin A, Ben-Gal Y, Keren G, Finkelstein A. Comparison of early and late outcomes of TAVI alone compared to TAVI plus PCI in aortic stenosis patients with and without coronary artery disease. Catheterization Cardiovas Interv. 2014;83:649\u201354.","journal-title":"Catheterization Cardiovas Interv"},{"key":"2374_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jacc.2019.06.012","volume":"74","author":"L Faroux","year":"2019","unstructured":"Faroux L, Guimaraes L, Wintzer-Wehekind J, Junquera L, Ferreira-Neto AN, Del Val D, Muntane-Carol G, Mohammadi S, Paradis JM, Rodes-Cabau J. Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74:362\u201372.","journal-title":"J Am Coll Cardiol"},{"key":"2374_CR35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/1745-6215-15-300","volume":"15","author":"MZ Khawaja","year":"2014","unstructured":"Khawaja MZ, Wang D, Pocock S, Redwood SR, Thomas MR. The percutaneous coronary intervention prior to transcatheter aortic valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial. Trials. 2014;15:300.","journal-title":"Trials"},{"key":"2374_CR36","doi-asserted-by":"crossref","unstructured":"Vilalta V, Asmarats L, Ferreira-Neto AN, Maes F, de Freitas Campos Guimaraes L, Couture T, Paradis JM, Mohammadi S, Dumont E, Kalavrouziotis D, Delarochelliere R and Rodes-Cabau J. Incidence, Clinical characteristics, and impact of acute coronary syndrome following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11:2523\u20132533.","DOI":"10.1016\/j.jcin.2018.09.001"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02374-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02374-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02374-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T14:27:35Z","timestamp":1638282455000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02374-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2374"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02374-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"assertion":[{"value":"12 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committee of University of Ulm. All patients provided written informed consent to participate in the ULM TAVR-Registry with subsequent follow-up assessment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"568"}}